Thursday, May 7, 2026

Kia Tasman and Musso EV: New Players Aim to Boost South Korea’s Sluggish Pickup Market

Kia and KG Mobility are set to launch new pickups, the Tasman and Musso EV, aiming to revitalize South Korea's stagnant market.

U.S., South Korea, and Japan Join Forces to Tackle North Korean Cyber Threats

South Korea, the U.S., and Japan enhance trilateral cyber defense against North Korean threats, focusing on collaboration and sanctions.

U.S. Treasury Pushes Back: Bessent Says No Yen Support, No Market Meddling—But the Dollar Weakness Trade Lives On

Trump's comments on tariffs and a weaker dollar have led to a decline in the dollar-won exchange rate, boosting the Korean won's strength.

Health

CG Bio Group Launches Acellular Dermal Matrix-based Product Reallo Inject Fine

CG Bio launches Reallo Inject Fine, an acellular dermal matrix product, enhancing usability for medical professionals and expanding applications.

Ceragem Launches Global Standard for AI Home Healthcare, Accelerates Data Platform Push

Ceragem's new ISO/IEC report sets international standards for integrating home healthcare devices, focusing on user well-being and safety.

Hugel Participates AMWC ASIA & TDAC 2026 at the Taipei International Convention Center, Taiwan

Hugel targets Taiwan's aesthetic market, showcasing products at AMWC ASIA & TDAC 2026, while expanding in Indonesia with educational programs.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Seers Signs $14.7 Million Contract with UAE to Supply 105,000 Units over 3 Years

Seers signs a major deal for mobiCARE devices in the UAE, aiming for 50% growth and expansion into Vietnam and beyond.
Latest

Hanmi Posts Record $1.16B Sales and $193M Operating Profit: What’s Driving the 2025 Surge

Hanmi Pharmaceutical reports record sales of $1.16 billion in January 2025, with significant growth in profits and new product launches.

FDA Grants Breakthrough Therapy Designation to Hanmi’s Epheglucagon: What This Means for Rare Disease Treatment

Hanmi Pharmaceutical's efpegerglucagon receives FDA Breakthrough Therapy designation for treating rare Congenital Hyperinsulinism, with Phase 2 results due soon.

Elanco’s Vision for 2030: Key Insights from CEO Jeffrey Simmons’ Visit to South Korea

Elanco CEO Jeffrey Simmons visited South Korea to discuss growth strategies, celebrate anniversaries, and emphasize employee partnership.

K-Beauty Boom: How Classys, Hugel, and Wontech are Expanding in Global Markets

The K-beauty industry is growing, leveraging strong manufacturing and R&D capabilities alongside the global spread of Hallyu.

Celltrion Gets Global IB Upgrades: Morgan Stanley Raises Target to $206.25 as New Biosimilars Lift Margins

Celltrion is expanding through biosimilars and new drug development, attracting global investor interest and raising target stock prices.

CM Hospital’s thynC System: The Future of Patient Monitoring and Safety in Healthcare

Daewoong Pharmaceutical launches thynC, an AI-powered monitoring system at CM Hospital to enhance patient safety and healthcare quality.

Rokit Healthcare Secures UAE Patent for AI-Based Cartilage Regeneration: A Game-Changer in Middle Eastern Joint Treatment

Rokit Healthcare secures a UAE patent for AI cartilage regeneration, targeting a $682M market and shifting focus to regenerative medicine.

How ABL Bio’s Grabody-B Revolutionizes siRNA Delivery: A Game-Changer for Brain Disease Treatment?

ABL Bio's Grabody-B technology effectively delivers siRNA across the blood-brain barrier, enhancing treatment for brain and systemic diseases.

How LG CNS and FuriosaAI Are Revolutionizing AI Infrastructure for the Public Sector

LG CNS partners with FuriosaAI to enhance AI services using neural processing units, targeting the public AI transformation market.

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

Revolutionary Vascular Wall Plug: How This New Device Enhances Blood Flow Control in 2026

Researchers unveil a novel vascular wall plug that enhances hemostasis and regulates blood flow, improving vascular procedure outcomes.

Samsung Biologics Joins CEPI: How This Partnership Will Revolutionize Vaccine Production in Asia

Samsung Biologics partners with CEPI to enhance vaccine manufacturing, aiming to strengthen global health security and support local biotech growth.

How thynC™ is Revolutionizing Patient Monitoring: Insights from Seers Technology’s Success

Seers Technology aims for global expansion, projecting overseas sales to match domestic by 2029, driven by its innovative AI healthcare solutions.

Samsung Biologics Partners with CEPI: A Game-Changer for Global Vaccine Production

Samsung Biologics partners with CEPI to enhance vaccine production for pandemics, aiming for rapid global supply and health security.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.